Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS5580 for prevention of postoperative nausea and vomiting
CTR20242176Phase 2Completed
- Sponsor
- Fujian Shengdi Pharmaceuticals
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosrolapitant in postoperative nausea and vomiting (PONV), sponsored by Fujian Shengdi Pharmaceuticals. Started Jun 2024; status: completed.
02
Drugs
fosrolapitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on CTR20242176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242176.